2015
DOI: 10.5301/tj.5000236
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: HFSRT offers a feasible and effective salvage treatment option for recurrent GBM management. Prognostic factors associated with longer OS in our study were longer interval between initial treatment and recurrence, smaller PTV size, KPS ≥70 and younger age.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
27
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 60 publications
(30 citation statements)
references
References 40 publications
3
27
0
Order By: Relevance
“…12,13 The comparably favourable result of median 28.8 months of overall survival after primary diagnosis is probably attributable to patient selection for re-irradiation. 12,13 The comparably favourable result of median 28.8 months of overall survival after primary diagnosis is probably attributable to patient selection for re-irradiation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…12,13 The comparably favourable result of median 28.8 months of overall survival after primary diagnosis is probably attributable to patient selection for re-irradiation. 12,13 The comparably favourable result of median 28.8 months of overall survival after primary diagnosis is probably attributable to patient selection for re-irradiation.…”
Section: Discussionmentioning
confidence: 99%
“…Outcome after re-irradiation in our patients is in line with reports by others. 12,13 The comparably favourable result of median 28.8 months of overall survival after primary diagnosis is probably attributable to patient selection for re-irradiation.…”
Section: Discussionmentioning
confidence: 99%
“…Herein, we provide a concise review of RT for temporal bone chemodectomas. and HFSRT has proved to be safe and effective for management of several intracranial and extracranial disorders [1,2,[84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101][102].…”
Section: Introductionmentioning
confidence: 99%
“…Of these, HFSRT has emerged as a noninvasive method to deliver a high dose of radiation to the tumor site. In the treatment of recurrent GBM, numerous studies have documented a survival advantage on the use of HFSRT [10][11][12][13][14][15][16][17][18] and HFSRT in combination with chemotherapy [19][20][21][22][23][24]. Specifically, Iuchi, et al [25] has shown that a single dose of more than 20 Gy is able to achieve durable local control in 72% of patients; however, radiation necrosis (RN) was observed in 43% of patients.…”
Section: Introductionmentioning
confidence: 99%